Bruker Corp. (NSDQ:BRKR) announced today that it acquired biomarker imaging technology developer Canopy Biosciences. Billerica, Mass.-based Bruker said in a news release that the acquisition, for which financial details were not disclosed, enhances its offering in targeted multi-omics and fluorescence-based imaging technologies and combines its global reach with Canopy’s success to date. Canopy develops high multiplex […]